Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays.

Weinberg A, Song LY, Wilkening CL, Fenton T, Hural J, Louzao R, Ferrari G, Etter PE, Berrong M, Canniff JD, Carter D, Defawe OD, Garcia A, Garrelts TL, Gelman R, Lambrecht LK, Pahwa S, Pilakka-Kanthikeel S, Shugarts DL, Tustin NB.

J Immunol Methods. 2010 Dec 15;363(1):42-50. doi: 10.1016/j.jim.2010.09.032. Epub 2010 Oct 1.

2.

Phenotypic and genotypic analysis of biologically cloned human immunodeficiency virus type 1 isolates from patients treated with zidovudine and lamivudine.

Stoeckli TC, MaWhinney S, Uy J, Duan C, Lu J, Shugarts D, Kuritzkes DR.

Antimicrob Agents Chemother. 2002 Dec;46(12):4000-3.

3.

Emergence of dual resistance to zidovudine and lamivudine in HIV-1-infected patients treated with zidovudine plus lamivudine as initial therapy.

Kuritzkes DR, Shugarts D, Bakhtiari M, Poticha D, Johnson J, Rubin M, Gingeras TR, Kennedy M, Eron JJ.

J Acquir Immune Defic Syndr. 2000 Jan 1;23(1):26-34.

PMID:
10708053
4.

Resistance mutations in protease and reverse transcriptase genes of human immunodeficiency virus type 1 isolates from patients with combination antiretroviral therapy failure.

Young B, Johnson S, Bahktiari M, Shugarts D, Young RK, Allen M, Ramey RR 2nd, Kuritzkes DR.

J Infect Dis. 1998 Nov;178(5):1497-501.

PMID:
9780274
5.

Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir.

Patick AK, Duran M, Cao Y, Shugarts D, Keller MR, Mazabel E, Knowles M, Chapman S, Kuritzkes DR, Markowitz M.

Antimicrob Agents Chemother. 1998 Oct;42(10):2637-44.

6.

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients.

Kuritzkes DR, Quinn JB, Benoit SL, Shugarts DL, Griffin A, Bakhtiari M, Poticha D, Eron JJ, Fallon MA, Rubin M.

AIDS. 1996 Aug;10(9):975-81.

PMID:
8853730
7.

The effects of triethyl lead on the development of hippocampal neurons in culture.

Audesirk T, Shugarts D, Cabell-Kluch L, Wardle K.

Cell Biol Toxicol. 1995 Feb;11(1):1-10.

PMID:
7600254
8.

Effects of inorganic lead on the differentiation and growth of cultured hippocampal and neuroblastoma cells.

Audesirk T, Audesirk G, Ferguson C, Shugarts D.

Neurotoxicology. 1991 Fall;12(3):529-38.

PMID:
1660584
9.

L-type calcium channels may regulate neurite initiation in cultured chick embryo brain neurons and N1E-115 neuroblastoma cells.

Audesirk G, Audesirk T, Ferguson C, Lomme M, Shugarts D, Rosack J, Caracciolo P, Gisi T, Nichols P.

Brain Res Dev Brain Res. 1990 Aug 1;55(1):109-20.

PMID:
1698574
10.

Organic and inorganic lead inhibit neurite growth in vertebrate and invertebrate neurons in culture.

Audesirk G, Shugarts D, Nelson G, Przekwas J.

In Vitro Cell Dev Biol. 1989 Dec;25(12):1121-8.

PMID:
2606878
11.

Relative mutagenicity of some urinary metabolites of the antitumor drug cyclophosphamide.

Balbinder E, Reich CI, Shugarts D, Keogh J, Fibiger R, Jones T, Banks A.

Cancer Res. 1981 Jul;41(7):2967-72.

Supplemental Content

Loading ...
Support Center